ATE286127T1 - Verabreichung der therapeutischen proteine durch implantation der genetischen modifizierten zellen in das omentum - Google Patents

Verabreichung der therapeutischen proteine durch implantation der genetischen modifizierten zellen in das omentum

Info

Publication number
ATE286127T1
ATE286127T1 AT99916683T AT99916683T ATE286127T1 AT E286127 T1 ATE286127 T1 AT E286127T1 AT 99916683 T AT99916683 T AT 99916683T AT 99916683 T AT99916683 T AT 99916683T AT E286127 T1 ATE286127 T1 AT E286127T1
Authority
AT
Austria
Prior art keywords
omentum
implantation
administration
genetically modified
therapeutic proteins
Prior art date
Application number
AT99916683T
Other languages
English (en)
Inventor
Justin Chase Lamsa
Douglas A Treco
Original Assignee
Transkaryotic Therapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transkaryotic Therapies Inc filed Critical Transkaryotic Therapies Inc
Application granted granted Critical
Publication of ATE286127T1 publication Critical patent/ATE286127T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99916683T 1998-04-24 1999-04-16 Verabreichung der therapeutischen proteine durch implantation der genetischen modifizierten zellen in das omentum ATE286127T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8298298P 1998-04-24 1998-04-24
PCT/US1999/008266 WO1999055866A1 (en) 1998-04-24 1999-04-16 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum

Publications (1)

Publication Number Publication Date
ATE286127T1 true ATE286127T1 (de) 2005-01-15

Family

ID=22174676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99916683T ATE286127T1 (de) 1998-04-24 1999-04-16 Verabreichung der therapeutischen proteine durch implantation der genetischen modifizierten zellen in das omentum

Country Status (8)

Country Link
EP (1) EP1071768B1 (de)
JP (1) JP2002513036A (de)
AR (1) AR019100A1 (de)
AT (1) ATE286127T1 (de)
AU (1) AU755723B2 (de)
CA (1) CA2326819A1 (de)
DE (1) DE69922941D1 (de)
WO (1) WO1999055866A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042442A2 (en) 1999-12-10 2001-06-14 Cytos Biotechnology Ag Activation of endogenous genes by genomic introduction of a replicon
US20150231182A1 (en) * 2012-09-07 2015-08-20 University Of Louisville Research Foundation, Inc. Cell systems and methods for delivering disease-specific therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012604A1 (en) * 1989-04-25 1990-11-01 Vacanti Joseph P Method for implanting large volumes of cells on polymeric matrices
PT101031B (pt) * 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
AU2195095A (en) * 1994-03-24 1995-10-09 University Of Washington Devices and methods for implanting transduced cells
WO1998015615A1 (en) * 1996-10-10 1998-04-16 Duke University Method of producing a thymic microenvironment that supports the development of dendritic cells

Also Published As

Publication number Publication date
CA2326819A1 (en) 1999-11-04
AU3494499A (en) 1999-11-16
AR019100A1 (es) 2001-12-26
HK1035206A1 (en) 2001-11-16
DE69922941D1 (de) 2005-02-03
JP2002513036A (ja) 2002-05-08
EP1071768B1 (de) 2004-12-29
AU755723B2 (en) 2002-12-19
EP1071768A1 (de) 2001-01-31
WO1999055866A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
ATE232396T1 (de) Oxydiertes thymosin beta 4
IT1170235B (it) Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare
BRPI0507169A (pt) polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
DE60111184D1 (de) Künstiche herzklappe
NO20013770L (no) Metoder og blandinger for å öke antall hvite blodceller
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
EP1244683A4 (de) 21 menschliche sekretierte proteine
DE69840932D1 (de) Zusammensetzungen und verfahren zur verstärkung der verabreichung von therapeutischen mitteln in zellen
NO870772D0 (no) Vevplasminogenaktivator for normale humane tykktarmceller.
NO20006113D0 (no) Anvendelse av cyklosporiner i behandlingen av inflammatoriske autoimmune sykdommer
NO20001905D0 (no) Forbindelser og deres anvendelse i farmasøytiske eller kosmetiske preparater
NO20001934L (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
DE60016363D1 (de) Aminoalkohol-Derivat und Medikament, das dieses Derivat enthält
DE69725754D1 (de) Eingekapselte Antikörper-produzierende Zellen
ATE286127T1 (de) Verabreichung der therapeutischen proteine durch implantation der genetischen modifizierten zellen in das omentum
JPH1135456A5 (de)
CY1112440T1 (el) Απογλυκοζυλιωμενη και αποσιαλιδωμενη μακρα πεντραξινη ρτχ3
DE69821227D1 (de) Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen
NO995692L (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse i terapi
ITRM990375A0 (it) Articolatore perfionato per la realizzazione di modelli in gesso.
DE68906245D1 (de) Therapeutisches mittel gegen aids.
DK13087A (da) Gensekvens til fremstilling af human serumalbumin i bacillus
EP1237901A4 (de) 28 menschliche sekretierte proteine
EP1228082A4 (de) 29 humansekretierte proteine
IL146128A0 (en) Expression of heparin-binding protein in recombinant mammalian cells

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties